REDUCTION OF POSTOPERATIVE COMPLICATIONS OF CARDIOPULMONARY BYPASS (CPB) SURGERY

摘要

Patients undergoing cardiopulmonary bypass surgery are treated perioperative ly with methylol transfer agents, such as Taurolidine. Patients undergoing crystallo id cardioplegia who are treated with Taurolidine show reduced levels of IL-6 and increased level s of IL-10 when compared to crystalloid cardioplegia patients administered a placebo. Crystalloid cardioplegia patients administered Taurolidine also show reduced levels of IL-6 and increased levels of IL-10 when compared to blood cardioplegia patients who were administered Taurolidine.